AG
QTTB icon

Algert Global’s Q32 Bio QTTB Stock Holding History

Algert Global’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,943
Closed -$56K – 1316
2022
Q3 		$56K Sell
1,943
-365
-16% -$14.9K ﹤0.01% 1134
2022
Q2 		$82K Buy
2,308
+283
+14% +$9.66K 0.01% 1133
2022
Q1 		$111K Sell
2,025
-1,746
-46% -$108K 0.01% 1103
2021
Q4 		$247K Sell
3,771
-745
-16% -$72.3K 0.03% 790
2021
Q3 		$640K Buy
4,516
+3,818
+547% +$486K 0.09% 435
2021
Q2 		$91K Buy
+698
New +$87.1K 0.03% 395
2020
Q4 		– Sell
-1,744
Closed -$336K – 510
2020
Q3 		$336K Buy
+1,744
New +$391K 0.11% 240

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Algert Global's QTTB Position: Q4 2022 in Review

Algert Global sold out of Q32 Bio (QTTB) in Q4 2022, closing a stake of 1,943 shares — an estimated $56K sold.

Algert Global first reported a position in QTTB in Q3 2020 and held it in 7 quarters. The position peaked at $640K in Q3 2021. 79 funds tracked by Wall St. Rank hold QTTB as of Q4 2022.

  • Algert Global reported no remaining Q32 Bio position as of Q4 2022 after selling out during the quarter.
  • Algert Global sold 1,943 Q32 Bio shares in Q4 2022, an estimated $56K.
  • Algert Global first reported a position in Q32 Bio in Q3 2020 and held it in 7 quarters.
  • Algert Global's Q32 Bio position peaked at $640K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2022.

Based on Algert Global's 13F filing for Q4 2022, filed 14 Feb 2023.